GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)

SKU

$726.75

Buy GHRP-2 & CJC-1295 No DAC Online – Synergistic Growth Hormone Research Blend. This research blend combines two potent synthetic peptides: GHRP-2, a hexapeptide growth hormone secretagogue, and CJC-1295 No DAC (Mod GRF 1-29), a stabilized GHRH analog. Designed for laboratories investigating the hypothalamic–pituitary axis, this pairing allows for the study of dual-receptor activation. At the Peptide Sciences Official Store, we provide HPLC-MS verified vials with guaranteed 99%+ purity. Every order includes a COA and is sent via discreet shipping to ensure your research remains secure and professional.

Add items to your cart, select your preferred payment method and place the order. NOTE: You will not be charged initially since all payments are made manually. 

Once your order is received, you’ll receive an email or SMS with payment details.
A tracking  code will be sent out once your payment has been fully received. You can also send us a message via the website Live Chat for q much faster response. 

For more details text us at: +1 629 331 9284 or send us an email or use the Live chat. 

PEPTIDE SCIENCES COUPON/DISCOUNT

To welcome researchers to our new platform, Peptide Sciences offers exclusive savings opportunities.

New customers can receive 10% off their first order using the official Peptide Sciences coupon code: PEPTIDESC10.

You can get up to 20% if you pay with Cryptocurrency (BITCOIN, USDT, ETH & more)

Description

GHRP-2 and CJC-1295 no DAC (Mod GRF 1-29) are synthetic research peptides used together in experimental models to investigate growth hormone axis regulation and somatotropic signaling pathways. GHRP-2 is a potent hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a), triggering Gq/PLC-dependent calcium signaling involved in GH release and hypothalamic–pituitary feedback regulation. CJC-1295 no DAC is a stabilized analog of growth hormone–releasing hormone (GHRH 1-29) that selectively activates the GHRH receptor, stimulating adenylate cyclase and cAMP-mediated signaling in pituitary somatotrophs. Preclinical research employs the combined activation of GHS-R1a and GHRH receptors to examine synergistic GH secretion, receptor pharmacology, and endocrine signaling dynamics in controlled laboratory settings.

Additional Information